Raymond James & Associates Enovis Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Enovis Corp stock. As of the latest transaction made, Raymond James & Associates holds 56,692 shares of ENOV stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,692

Previous 4,818 1076.67%

Holding current value

$2.49 Million

Previous $217,000 1024.42%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$40.57 - $48.1 $2.1 Million - $2.5 Million	51,874 Added 1076.67%	56,692 $2.44 Million
Q2 2024 Jul 19, 2024	BUY	$44.56 - $62.43 $43,980 - $61,618	987 Added 25.76%	4,818 $217,000
Q1 2024 Apr 22, 2024	SELL	$55.44 - $63.8 $1,940 - $2,233	-35 Reduced 0.91%	3,831 $239,000
Q4 2023 Jan 16, 2024	SELL	$43.67 - $57.07 $15,066 - $19,689	-345 Reduced 8.19%	3,866 $216,000
Q3 2023 Oct 24, 2023	SELL	$51.65 - $65.54 $28,872 - $36,636	-559 Reduced 11.72%	4,211 $222,000
Q2 2023 Jul 25, 2023	BUY	$52.7 - $64.12 $13,069 - $15,901	248 Added 5.48%	4,770 $305,000
Q1 2023 Apr 14, 2023	SELL	$49.5 - $65.92 $3,415 - $4,548	-69 Reduced 1.5%	4,522 $241,000
Q4 2022 Feb 08, 2023	SELL	$44.83 - $57.43 $1.12 Million - $1.44 Million	-25,075 Reduced 84.52%	4,591 $245,000
Q3 2022 Oct 25, 2022	SELL	$46.07 - $60.1 $417,947 - $545,227	-9,072 Reduced 23.42%	29,666 $1.37 Million
Q2 2022 Aug 12, 2022	BUY	$55.0 - $70.47 $2.13 Million - $2.73 Million	38,738 New	38,738 $2.13 Million

Others Institutions Holding ENOV

# of Institutions

310

Shares Held

60.2M

Call Options Held

1.68M

Put Options Held

693K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Enovis Corp Transaction History